BPT Pharmaceuticals

BPT Pharmaceuticals is developing a biomarker assay for Multiple Sclerosis (MS). The test is designed to enable clinicians to assess neurological damage caused by MS and to follow both the progression of disease and the response to treatment.

PUBLICATION COMING SOON